Caution should be used before using the APOE e4 as a predictor of health care costs.
Publication
, Journal Article
Taylor Jr, DH
Published in: Expert Review of Pharmacoeconomics and Outcomes Research
2003
Duke Scholars
Published In
Expert Review of Pharmacoeconomics and Outcomes Research
Publication Date
2003
Volume
3
Start / End Page
569 / 573
Related Subject Headings
- Health Policy & Services
- 1402 Applied Economics
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Taylor Jr, D. H. (2003). Caution should be used before using the APOE e4 as a predictor of health care costs. Expert Review of Pharmacoeconomics and Outcomes Research, 3, 569–573.
Taylor Jr, D. H. “Caution should be used before using the APOE e4 as a predictor of health care costs.” Expert Review of Pharmacoeconomics and Outcomes Research 3 (2003): 569–73.
Taylor Jr DH. Caution should be used before using the APOE e4 as a predictor of health care costs. Expert Review of Pharmacoeconomics and Outcomes Research. 2003;3:569–73.
Taylor Jr, D. H. “Caution should be used before using the APOE e4 as a predictor of health care costs.” Expert Review of Pharmacoeconomics and Outcomes Research, vol. 3, 2003, pp. 569–73.
Taylor Jr DH. Caution should be used before using the APOE e4 as a predictor of health care costs. Expert Review of Pharmacoeconomics and Outcomes Research. 2003;3:569–573.
Published In
Expert Review of Pharmacoeconomics and Outcomes Research
Publication Date
2003
Volume
3
Start / End Page
569 / 573
Related Subject Headings
- Health Policy & Services
- 1402 Applied Economics
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences